Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Stem Cells. 2015 Jan;33(1):278–288. doi: 10.1002/stem.1852

Fig. 3. NR4A1GFP+ LSKs are preserved after treatment with 5-Florouracil.

Fig. 3

NR4A1GFP Tg reporter mice were treated with 5-fluorouracil (5-FU) or an equivalent volume of PBS via intraperitoneal injection. Mice were euthanized 42h after treatment, and Lin BM cells were isolated, stained and analyzed by FACS. (A) CD150 and CD48 expression levels of LSK cells from 5-FU treated and control mice (left). The bar graph (right) shows the average proportion of LT-HSCs among LSKs after 5-FU or vehicle treatment (data are from two independent experiments with a total of three 5-FU-treated NR4A1GFP transgenic (Tg) mice; three vehicle-treated Tg mice; two 5-FU-treated littermate control (LMC) mice; two vehicle-treated LMC mice). (B) NR4A1GFP expression of LT-HSCs (CD48CD150+ LSKs) from 5-FU and vehicle treated mice (left). The bar graph (right) shows the proportion of NR4A1GFP+ LT-HSCs from the three 5-FU-treated Tg mice and the three vehicle-treated Tg mice. P-values were calculated using unpaired, one-tailed student’s t-test.